Cinctive Capital Management LP

Position in MDGL — Madrigal Pharmaceuticals, Inc.

CIK 1787258 New York, NY

Position in MDGL

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$8,022,701

+$5,875,614 QoQ

Shares Held

15,326

+315.7% QoQ

Ownership

0.066%

of shares outstanding

% of Portfolio

0.53%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Cinctive Capital Management LP holds $185,949,026 across 51 Biotechnology names. MDGL ranks #8 (4.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	73,063	$11,947,261
2	BBIO	BridgeBio Pharma, Inc.	145,728	$10,821,761
3	NTHI	Neonc Technologies Holdings, Inc.	1,425,526	$9,992,937
4	DAWN	Day One Biopharmaceuticals, Inc.	450,000	$9,648,000
5	ACLX	Arcellx, Inc.	80,000	$9,185,600
6	RVMD	Revolution Medicines, Inc.	93,857	$9,127,593
7	SRRK	Scholar Rock Holding Corp	172,535	$8,481,820
8	MDGL	Madrigal Pharmaceuticals, Inc. This page	15,326	$8,022,701

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$8,022,701	15,326	+315.7%	Shares	Sole	2026-05-15
2025-12-31	$2,147,087	3,687	+2.2%	Shares	Sole	2026-02-17
2025-09-30	$1,653,927	3,606	-24.4%	Shares	Sole	2025-11-14
2025-06-30	$1,442,987	4,768	+337.0%	Shares	Sole	2025-08-14
2025-03-31	$361,371	1,091	-79.8%	Shares	Sole	2025-05-15
2024-12-31	$1,668,129	5,406	+6.5%	Shares	Sole	2025-02-12
2024-09-30	$1,076,804	5,074	+115.9%	Shares	Sole	2024-11-14
2023-12-31	$543,743	2,350	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.